Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor Clinical Trials in Kunming, Yunnan

A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation